MAINZ, Germany, March 28, 2023(Nasdaq: BNTX, "BioNTech" or the "Company") today announced that it has entered into a new share repurchase program (the "Program"), pursuant to which the Company may purchase
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BioNTech to receive exclusive worldwide license from OncoC4 to develop and commercialize its anti-CTLA-4 monoclonal antibody candidate, ONC-392BioNTech and.
Investegate announcements from BioNTech SE, BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel
JERUSALEM, Israel, March 1, 2023 - BioNTech SE(Nasdaq: BNTX, "BioNTech", "the Company") announced that the Company and the Weizmann Institute of Science ("Weizmann Institute") signed a Memorandum